United States · Who invested in ApoGen?
ApoGen's investors include ARCH Venture Partners, Eli Lilly, AbbVie and M Venturess.
United States · Series A startup
Who invested in ApoGen
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$4.0Mraised across 1 round since 2018, from 2 sources
- Latest round
- Series A, $4.0MAug 2018
- Investors
- 4
The rounds
- Aug 2018Series A$4.0M
ARCH Venture Partners
Eli Lilly
AbbVie- M Venturess
Reported by FinSMEs and 1 otherSEC filing: $7.6M sold, first sale Nov 2016
Everyone who backed them
M Venturessno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ApoGen
How much has ApoGen raised?
ApoGen has raised $4.0M across 1 round since 2018.
When did ApoGen last raise?
ApoGen's most recent round was a Series A of $4.0M in Aug 2018.
What was ApoGen's biggest round?
Its most recent round, $4.0M in Aug 2018, is also its largest on record.
Who backed ApoGen first?
ApoGen's first round on record, in Aug 2018, was backed by ARCH Venture Partners, Eli Lilly and AbbVie and 1 others.
What stage is ApoGen at?
ApoGen's latest named round is a Series A, in Aug 2018.
Where is ApoGen based?
ApoGen is based in the United States.
Companies like ApoGen
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.